Effect of intrathecal morphine on the quality of recovery after pulmonary surgery
Conditions
Interventions
Control Group (Nalbuphine 0.4mg/ml combined with sufentanil 1µg/ml+ ondansetron 8mg):None
Experimental Group(Hydromorifone 10mg+ esamamine 50mg+ Nalbuphine 40mg+ obebe 8mg+ betamethasone 20mg+ butorphine tartrate injection 2mg to 0.9% sodium chloride injection):None
Sponsors
Yichang Central People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.Age > 18 years old; 2.Patients who are scheduled to undergo PCIA after general anesthesia surgery; 3.Be able to understand the process and methods of this research, voluntarily participate and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1.Patients who adopt other analgesic methods or multiple analgesic approaches; 2.Patients with a previous history of allergies or allergies to anesthetic drugs; 3.Patients with language expression disorders or inability to communicate; 4.Patients who the researchers consider unsuitable to participate.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| VAS Resting and Active Pain Score (T0, T1, T2); | — |
Secondary
| Measure | Time frame |
|---|---|
| Number of PCA compressions (T1, T2);Remedial analgesic drugs and the frequency of remedial analgesia (T2);The incidences of drowsiness, dizziness, nausea, vomiting, respiratory depression and other adverse reactions (T0, T1, T2); | — |
Countries
China
Contacts
Public ContactYuan Gong
Yichang Central People's Hospital
Outcome results
None listed